SEC Form 4
Zura Bio Limited (ZURA) insider trading
In the 12 months to Nov 19, 2026, one ZURA insider reported open-market purchases of $12.5M across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $12.5M
- 1 filing · Len Blavatnik, 10% owner
Who traded ZURA, and when
- Purchase
ZURA daily close from Nov 19, 2025 to Nov 18, 2026, between $0.97 and $7.04, last $0.97. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Len Blavatnik, 10% owner: bought $12.5M across 1 filing, first filed Mar 2, 2026, last Mar 2, 2026.
Largest mark · tap a row for others
Len Blavatnik · 10% owner
Purchase $12,500,000
2,000,000 shares
Filed Mar 2, 2026 · traded Feb 26
Close on filing date $6.76
Len Blavatnik · 10% owner
10% owner
$12.5M boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Len Blavatnik | 10% owner | — | $12.5M | 1 | — |
| Filed | Insider | Type | Shares | Value | Held after | Source |
|---|---|---|---|---|---|---|
traded | Len Blavatnik 10% owner | Purchase | 2,000,000 ordinary shares | $12.5M | 6,552,725 |
Shares are as filed (ordinary shares or ADS); values are as converted to US$ in the filing.
GET /stocks/filings/vX/form-4?tickers=ZURA&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"JATT",
"ZURA"
],
"issuer_cik": "0001855644",
"owner_cik": "0001326628",
"accession_number": "0001193125-26-085900",
"form_type": "4",
"filing_date": "2026-03-02",
"period_of_report": "2026-02-26",
"issuer_name": "Zura Bio Ltd",
"issuer_trading_symbol": "ZURA",
"owner_name": "Blavatnik Len",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-02-26",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 2000000,
"transaction_price_per_share": 6.25,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 6552725,
"transaction_value": 12500000,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer."
},
{
"id": "F2",
"description": "The securities reported are held directly by AI Biotechnology LLC (\"AIB\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."
}
]
},
{
"tickers": [
"JATT",
"ZURA"
],
"issuer_cik": "0001855644",
"owner_cik": "0001942670",
"accession_number": "0001193125-26-085900",
"form_type": "4",
"filing_date": "2026-03-02",
"period_of_report": "2026-02-26",
"issuer_name": "Zura Bio Ltd",
"issuer_trading_symbol": "ZURA",
"owner_name": "AI Biotechnology LLC",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-02-26",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 2000000,
"transaction_price_per_share": 6.25,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 6552725,
"transaction_value": 12500000,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer."
},
{
"id": "F2",
"description": "The securities reported are held directly by AI Biotechnology LLC (\"AIB\") and may be deemed to be beneficially owned by Access Industries Holdings LLC (\"AIH\"), Access Industries Management, LLC (\"AIM\") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Zura Bio Limited's CEO sold stock?
No. Sandeep Chidambar Kulkarni (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is ZURA’s insider data?
These are ZURA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track ZURA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ZURA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.